Device type · OZO
Automated Insulin Dosing , Threshold Suspend
Last checked: Nov 19, 2026Source: openFDAMethods & limitations
Product code
OZO
Clinical Chemistry
Device class
Class III
FDA decisions since 2015
4
510(k), De Novo and PMA
Adverse event reports
1,554
Received Nov 1, 2025 to Nov 19, 2026
How FDA classifies it
- Device type
- Automated Insulin Dosing , Threshold Suspend
- Product code
- OZO
- Device class
- Class III
- Review panel
- Clinical Chemistry
- FDA record
- Classification database entry for OZO
Latest FDA decisions
P180008 · Decided Jun 21, 2018 · 115 days after receipt
Device type: Automated insulin dosing , threshold suspend (OZO) · Laboratory Medicine & Pathology
- MiniMed 630G SystemPMA supplement
P150001-S021 · Decided Feb 13, 2018 · 195 days after receipt · Panel Track
Device type: Automated insulin dosing , threshold suspend (OZO) · Laboratory Medicine & Pathology
P150001 · Decided Aug 10, 2016 · 580 days after receipt
Device type: Automated insulin dosing , threshold suspend (OZO) · Laboratory Medicine & Pathology
1 more FDA decisions with a free account
Reports received
1,554
Received Nov 1, 2025 to Nov 19, 2026
Malfunction reports
1,371
88% of reports
Injury reports
174
11% of reports
Death reports
9
0.6% of reports
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 1,691 | 390 | 7 | 0 |
| Jan 24 | 1,344 | 616 | 8 | 0 |
| Feb 24 | 1,132 | 149 | 5 | 1 |
| Mar 24 | 1,126 | 173 | 8 | 0 |
| Apr 24 | 908 | 87 | 2 | 0 |
| May 24 | 1,089 | 96 | 8 | 0 |
| Jun 24 | 971 | 114 | 9 | 0 |
| Jul 24 | 821 | 557 | 8 | 0 |
| Aug 24 | 531 | 145 | 11 | 0 |
| Sep 24 | 434 | 46 | 0 | 0 |
| Oct 24 | 368 | 44 | 4 | 0 |
| Nov 24 | 322 | 145 | 0 | 0 |
| Dec 24 | 495 | 34 | 3 | 0 |
| Jan 25 | 442 | 64 | 0 | 0 |
| Feb 25 | 267 | 17 | 2 | 0 |
| Mar 25 | 313 | 35 | 3 | 0 |
| Apr 25 | 395 | 131 | 3 | 0 |
| May 25 | 352 | 28 | 2 | 0 |
| Jun 25 | 236 | 24 | 6 | 0 |
| Jul 25 | 243 | 18 | 2 | 0 |
| Aug 25 | 199 | 25 | 2 | 0 |
| Sep 25 | 322 | 13 | 1 | 0 |
| Oct 25 | 179 | 20 | 0 | 0 |
| Nov 25 | 118 | 5 | 0 | 0 |
| Dec 25 | 170 | 14 | 2 | 0 |
| Jan 26 | 155 | 12 | 0 | 0 |
| Feb 26 | 179 | 9 | 2 | 0 |
| Mar 26 | 132 | 11 | 0 | 0 |
| Apr 26 | 122 | 9 | 1 | 0 |
| May 26 | 79 | 17 | 0 | 0 |
| Jun 26 | 104 | 36 | 0 | 0 |
| Jul 26 | 84 | 14 | 0 | 0 |
| Aug 26 | 75 | 21 | 1 | 0 |
| Sep 26 | 74 | 14 | 3 | 0 |
| Oct 26 | 79 | 12 | 0 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
- Medtronic1,548
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
- Break446
- Obstruction of Flow375
- Battery Problem339
7 more in this ranking with a free account
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
- No Clinical Signs, Symptoms or Conditions1,257
- Hyperglycemia211
- Hypoglycemia72
7 more in this ranking with a free account
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-1740-2026 · Started Feb 13, 2026 · Posted by FDA Apr 2, 2026
Reason given: All Medtronic MiniMed infusion pumps (Paradigm series, 600 series, and BLE 700 series) were found to be affected by unintended over- and under-delivery of insulin when the pump is elevated or lowered relative to the infusion site, respectively, because of changes in gravitational force impacting hydrostatic and...
Cause as FDA categorized it: Device Design
- MiniMed 530G Insulin Pump (MMT-551, MMT-751)Open, Classified
Z-1751-2026 · Started Feb 13, 2026 · Posted by FDA Apr 2, 2026
Reason given: All Medtronic MiniMed infusion pumps (Paradigm series, 600 series, and BLE 700 series) were found to be affected by unintended over- and under-delivery of insulin when the pump is elevated or lowered relative to the infusion site, respectively, because of changes in gravitational force impacting hydrostatic and...
Cause as FDA categorized it: Device Design
Z-1259-2025 · Started Jan 31, 2025 · Posted by FDA Mar 3, 2025
Reason given: All Medtronic MiniMed pumps (Paradigm series, Minimed 530G, 6XX series, and 7XX series) were found to have the potential for abnormal insulin delivery due to changes in air pressure, which can be found during airplane take-off or landing. An unexpected additional dose of insulin, which can occur during take-off, can...
Cause as FDA categorized it: Device Design
8 more recall records with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.